These data support the use of sacituzumab plus pembrolizumab as a potential new standard of care,” said Sara Tolaney, MD.

A rare dual-nurse role is emerging in the U.S. that could serve as a powerful aid to systems: clinically based nurse scientists. Nurse scientists, also referred to as nurse researchers, are nurses who ...